论文部分内容阅读
目的探讨BIPAP治疗慢性阻塞性肺疾病并Ⅱ型呼吸衰竭临床疗效。方法回顾分析130例患者的临床资料。结果治疗组65例患者,均完成经面罩BIPAP无创通气的操作。其中63例耐受良好,1例无创机械通气失败,1例因病情变化而改气管插管行有创通气治疗,其余患者均经治疗后血气指标PaO2、SaO2明显上升,PaCO2明显下降,病情缓解而出院。平均上机6d,平均住院12d。结论采用BIPAP治疗慢性阻塞性肺疾病(COPD)并发Ⅱ型呼吸衰竭,疗效确切,值得临床应用。
Objective To investigate the clinical efficacy of BIPAP in the treatment of chronic obstructive pulmonary disease (COPD) and type Ⅱ respiratory failure. Methods The clinical data of 130 patients were retrospectively analyzed. Results In the treatment group, 65 patients underwent noninvasive ventilation with mask BIPAP. Sixty-three patients were well-tolerated and one patient had failed noninvasive mechanical ventilation. One patient suffered from invasive ventilation after tracheal intubation due to changes of the disease. The rest of the patients were significantly increased in PaO2 and SaO2, PaCO2, And discharged. The average machine 6d, the average hospital 12d. Conclusion BIPAP treatment of chronic obstructive pulmonary disease (COPD) complicated by respiratory failure of type Ⅱ, curative effect is exact, worthy of clinical application.